Dk. Monteith et al., IMMUNE STIMULATION - A CLASS EFFECT OF PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES IN RODENTS, Anti-cancer drug design, 12(5), 1997, pp. 421-432
Treatment of rodents with phosphorothioate oligodeoxynucleotides induc
es a form of immune stimulation characterized by splenomegaly, lymphoi
d hyperplasia, hypergammaglobulinemia and mixed mononuclear cellular i
nfiltrates in numerous tissues. Immune stimulation was evaluated in mi
ce with in vivo and in vitro studies using a review of historical data
and specific in vivo and in vitro studies. All phosphorothioate oligo
deoxynucleotides evaluated induced splenomegaly and B-lymphocyte proli
feration. Splenomegaly and B-lymphocyte proliferation increased with d
ose or concentration of oligodeoxynucleotide. Splenomegaly appeared to
occur, at least in part, as a result of stimulation of B-lymphocyte p
roliferation. There were differences with respect to degree or potency
of immune stimulation by different oligodeoxynucleotides. The rank or
der potencies for B-lymphocyte proliferation in vitro and splenomegaly
correlated well for the oligodeoxynucleotides tested. Particular olig
odeoxynucleotide sequence motifs or palindromes have been demonstrated
to affect in vitro cell proliferation. Inclusion of a 5'-AACGTT-3' pa
lindrome in a phosphorothioate oligodeoxynucleotide sequence significa
ntly enhanced the potency. While inclusion of this palindrome or a CpG
motif alone may contribute to the immune stimulation, these palindrom
es and motifs were clearly not the sole factor required for immune sti
mulation. Several phosphorothioate oligodeoxynucleotides that did not
contain a CpG motif still induced immune stimulation in mice. The immu
ne stimulation induced by phosphorothioate oligodeoxynucleotides was a
n effect of this class of compounds to which rodents are acutely sensi
tive.